New global phase IIa study evaluates tezepelumab for moderate to very severe COPD Aug. 27, 2019 No Comments
Phase II biomarker study of oral dexpramipexole in moderate to severe eosinophilic asthma Aug. 20, 2019 No Comments
CureVac, Yale to jointly discover mRNA-based candidates for pulmonary diseases Aug. 14, 2019 No Comments
Positive phase II data presented for dry powder inhaler formulation of ensifentrine Aug. 5, 2019 No Comments
RSS